Najera, Isabel

Publishing since 1999 (Senior)

Has published 8 publications in 11 years

Number of publications published per year by Najera, Isabel. (Source : PubMed)

Distribution of publications types for Najera, Isabel. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Chua PK, McCown MF, Rajyaguru S, Kular S, Varma R, Symons J, Chiu SS, Cammack N, Nájera I. Modulation of alpha interferon anti-hepatitis C virus activity by ISG15.  J. Gen. Virol.  2009;90;Pt 12  
•  Pockros PJ, Nelson D, Godofsky E, Rodriguez-Torres M, Everson GT, Fried MW, Ghalib R, Harrison S, Nyberg L, Shiffman ML, Najera I, Chan A, Hill G. R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin.  Hepatology  2008;48;2  
•  Roberts SK, Cooksley G, Dore GJ, Robson R, Shaw D, Berns H, Hill G, Klumpp K, Najera I, Washington C. Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C.  Hepatology  2008;48;2  
•  Le Pogam S, Jiang WR, Leveque V, Rajyaguru S, Ma H, Kang H, Jiang S, Singer M, Ali S, Klumpp K, Smith D, Symons J, Cammack N, Nájera I. In vitro selected Con1 subgenomic replicons resistant to 2'-C-methyl-cytidine or to R1479 show lack of cross resistance.  Virology  2006;351;2  
•  Maffuz A, Barroso-Bravo S, Nájera I, Zarco G, Alvarado-Cabrero I, Rodríguez-Cuevas SA. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.  J. Exp. Clin. Cancer Res.  2006;25;2  
•  Le Pogam S, Kang H, Harris SF, Leveque V, Giannetti AM, Ali S, Jiang WR, Rajyaguru S, Tavares G, Oshiro C, Hendricks T, Klumpp K, Symons J, Browner MF, Cammack N, Nájera I. Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus.  J. Virol.  2006;80;12  
•  Gallegos-Hernández JF, Chávez-García MA, Nájera I, Ramírez-Ramírez L, Durán-Martínez M. [lymphatic Mapping and Sentinel Lymph Node Biopsy in patients with Breast Cancer ]  Gac Med Mex  2003;139;3  
•  Harrigan PR, Stone C, Griffin P, Nájera I, Bloor S, Kemp S, Tisdale M, Larder B. Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative Group.  J. Infect. Dis.  2000;181;3  

[ See timeline ] [ See all publications ]